SCHEMBL9213295

SCHEMBL9213295

Nc1nc(Cl)nc2c1ncn2C1C(Cl)=CC(O)C1O

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADORA3 P0DMS8 12/20 0.57
ADORA2A P29274 4/20 0.57
ADORA1 P30542 4/20 0.57
HSP90AA1 P07900 2/20 0.51
HSP90B1 P14625 2/20 0.51
PDE4D Q08499 2/20 0.51
PDE3A Q14432 2/20 0.51
PDE2A O00408 1/20 0.51
ADRA1A P35348 1/20 0.51
TMEM97 Q5BJF2 1/20 0.51
SIGMAR1 Q99720 1/20 0.51
AHCY P23526 1/20 0.50
PNP P00491 1/20 0.49
LMNA P02545 1/20 0.49
TP53 P04637 1/20 0.49
HTT P42858 1/20 0.49
SMN1; SMN2 Q16637 1/20 0.49
RXFP1 Q9HBX9 1/20 0.49
CDK1 P06493 1/20 0.48
CA1 P00915 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9213287 1.00 ADORA3 (0.57) ADORA3ADORA2AADORA1HSP90AA1HSP90B1
SCHEMBL9219846 0.87 AHCY (0.67) ADORA3ADORA2AADORA1HSP90AA1HSP90B1
SCHEMBL9219837 0.87 AHCY (0.67) ADORA3ADORA2AADORA1HSP90AA1HSP90B1
SCHEMBL9214589 0.83 AHCY (0.72) AHCY
SCHEMBL9214583 0.83 AHCY (0.72) AHCY
SCHEMBL9217782 0.83 AHCY (0.72) AHCY
SCHEMBL12125032 0.79 ADORA3 (0.53) ADORA3ADORA2AADORA1HSP90AA1HSP90B1
SCHEMBL9213189 0.75 AHCY (0.73) ADORA3ADORA2AADORA1HSP90AA1HSP90B1
SCHEMBL9213196 0.75 AHCY (0.73) ADORA3ADORA2AADORA1HSP90AA1HSP90B1
SCHEMBL864735 0.74 AHCY (0.60) AHCYSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0347852-B1 Novel neplanocin derivatives MERRELL DOW PHARMA (US) 1995-08-23 EP claimed
EP-0347852-A2 Novel neplanocin derivatives MERRELL DOW PHARMACEUTICALS INC. (US) 1989-12-27 EP claimed
EP-2522352-B1 Methods for stem cells modulation AGENCY SCIENCE TECH & RES (SG) 2017-01-11 EP disclosed
EP-2522352-A1 Methods for cancer therapy and stem cell modulation Agency for Science, Technology and Research (SG) 2012-11-14 EP disclosed
EP-0347852-B1 Novel neplanocin derivatives MERRELL DOW PHARMA (US) 1995-08-23 EP disclosed
EP-0347852-A2 Novel neplanocin derivatives MERRELL DOW PHARMACEUTICALS INC. (US) 1989-12-27 EP disclosed